Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma

U16-binding protein 4 (ULBP4), a human ligand for natural killer group 2, member D (NKG2D) receptor on NK cells and subsets of T cells, is thought to activate anticancer immune responses. However, the expression pattern and prognostic effect of ULBP4 in nasopharyngeal carcinoma (NPC) has not been in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Xu, Yuanji, Zhou, Lin, Zong, Jingfeng, Ye, Yunbin, Chen, Gang, Chen, Yanping, Liao, Xuehong, Guo, Qiaojuan, Qiu, Sufang, Lin, Shaojun, Chen, Honglin, Pan, Jianji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522045/
https://ncbi.nlm.nih.gov/pubmed/28159927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14917
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia